​

Soleno Therapeutics Ownership | Who Owns Soleno Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Soleno Therapeutics Ownership Summary

Soleno Therapeutics is owned by 112.33% institutional investors, 1.79% insiders. Janus henderson group is the largest institutional shareholder, holding 12.39% of SLNO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.81% of its assets in Soleno Therapeutics shares.

SLNO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSoleno Therapeutics112.33%1.79%-14.12%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group5.19M12.39%$233.13M
Vivo capital3.96M7.84%$331.63M
Adage capital partners gp3.58M7.08%$299.59M
Blackrock funding, inc. /de2.84M5.63%$238.33M
Blackrock1.86M5.15%$76.03M
Vanguard group1.88M4.50%$84.71M
Avoro capital advisors2.05M4.06%$171.75M
Price t rowe associates inc /md/1.63M3.89%$73.30M
Commodore capital lp1.52M3.64%$68.55M
Westfield capital management co lp1.43M2.83%$119.78M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vivo capital3.96M33.94%$331.63M
Ally bridge group (ny)178.82K12.47%$14.98M
Artia global partners lp494.42K7.94%$22.22M
Acuta capital partners63.44K7.42%$5.31M
Commodore capital lp1.52M5.02%$68.55M
Ghost tree capital300.00K3.83%$12.24M
Superstring capital management lp33.69K3.34%$2.82M
Nantahala capital management1.00M3.29%$83.89M
Silverarc capital management204.59K3.16%$17.14M
Avoro capital advisors2.05M3.01%$171.75M

Top Buyers

HolderShares% AssetsChange
Blackrock1.86M0.00%1.54M
Janus henderson group5.19M0.12%1.11M
Blackrock funding, inc. /de2.84M0.00%931.42K
Rtw investments, lp424.41K0.51%424.41K
Logos global management lp350.00K1.84%350.00K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors430.44K1.34%-1.08M
Vestal point capital, lp---1.06M
Point72 asset management---916.00K
Adage capital partners gp3.58M0.50%-816.73K
Nantahala capital management1.00M3.29%-755.67K

New Positions

HolderShares% AssetsChangeValue
Rtw investments, lp424.41K0.51%424.41K$35.56M
Logos global management lp350.00K1.84%350.00K$15.73M
Zimmer partners, lp120.60K0.22%120.60K$10.10M
Nan fung trinity (hk)102.95K1.03%102.95K$8.63M
Peregrine capital management93.00K0.19%93.00K$6.29M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Signaturefd-2.00
Stephens consulting-3.00
Ifp advisors-4.00
Harbour investments-5.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252571.58%56,707,4745.32%1120.83%16214.89%51-10.53%
Mar 31, 202526035.42%54,569,8436.92%1180.80%14512.40%59110.71%
Dec 31, 202449-68.59%6,917,396-85.32%160.13%35-66.02%6-75.00%
Sep 30, 202415631.09%47,121,2808.78%1120.79%10330.38%24-4.00%
Jun 30, 202411910.19%43,316,98021.90%1191.24%793.95%2566.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.49M2.81%18.04K
T. Rowe Price US All-Cap Opp Eq Comp1.12M2.74%390.37K
T. Rowe Price All-Cap Opportunities Fund1.27M2.38%142.86K
Vanguard US Total Market Shares ETF913.59K1.99%-
iShares Russell 2000 ETF967.86K1.82%-
Polar Capital Biotech S Inc925.00K1.74%107.50K
T. Rowe Price Health Sciences924.65K1.74%338.20K
Janus Henderson Global Life Sciences905.88K1.72%-17.78K
Janus Henderson Global Life Sciences D905.88K1.70%-13.95K
Strategic Advisers Fidelity US TtlStk849.94K1.60%808.44K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 01, 2025Hirano Patricia C SEE REMARKSSell$316.97K
Jun 24, 2025Hirano Patricia C SEE REMARKSSell$22.41K
Apr 01, 2025Hirano Patricia C SEE REMARKSSell$265.16K
Mar 28, 2025Pauls Matthew-Sell$424.80K
Mar 27, 2025Yen Kristen SEE REMARKSSell$116.70K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3-1
2025 Q2-2
2025 Q1-83
2024 Q4-8

SLNO Ownership FAQ

Who Owns Soleno Therapeutics?

Soleno Therapeutics shareholders are primarily institutional investors at 112.33%, followed by 1.79% insiders and -14.12% retail investors. The average institutional ownership in Soleno Therapeutics's industry, Biotech Stocks , is 307.10%, which Soleno Therapeutics falls below.

Who owns the most shares of Soleno Therapeutics?

Soleno Therapeutics’s largest shareholders are Janus henderson group (5.19M shares, 12.39%), Vivo capital (3.96M shares, 7.84%), and Adage capital partners gp (3.58M shares, 7.08%). Together, they hold 27.31% of Soleno Therapeutics’s total shares outstanding.

Does Blackrock own Soleno Therapeutics?

Yes, BlackRock owns 5.15% of Soleno Therapeutics, totaling 1.86M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 76.03M$. In the last quarter, BlackRock increased its holdings by 1.54M shares, a 471.09% change.

Who is Soleno Therapeutics’s biggest shareholder by percentage of total assets invested?

Vivo capital is Soleno Therapeutics’s biggest shareholder by percentage of total assets invested, with 33.94% of its assets in 3.96M Soleno Therapeutics shares, valued at 331.63M$.

Who is the top mutual fund holder of Soleno Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Soleno Therapeutics shares, with 2.81% of its total shares outstanding invested in 1.49M Soleno Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools